- Home
- DRVN vs BLTE Comparison
DRVN vs BLTE Comparison
Compare DRVN & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRVN
- BLTE
- Stock Information
- Founded
- DRVN 1972
- BLTE 2018
- Country
- DRVN United States
- BLTE United States
- Employees
- DRVN N/A
- BLTE N/A
- Industry
- DRVN Automotive Aftermarket
- BLTE Biotechnology: Pharmaceutical Preparations
- Sector
- DRVN Consumer Discretionary
- BLTE Health Care
- Exchange
- DRVN Nasdaq
- BLTE Nasdaq
- Market Cap
- DRVN 2.4B
- BLTE 2.6B
- IPO Year
- DRVN 2021
- BLTE 2022
- Fundamental
- Price
- DRVN $14.12
- BLTE $111.81
- Analyst Decision
- DRVN Strong Buy
- BLTE Strong Buy
- Analyst Count
- DRVN 8
- BLTE 5
- Target Price
- DRVN $20.63
- BLTE $105.00
- AVG Volume (30 Days)
- DRVN 1.1M
- BLTE 101.9K
- Earning Date
- DRVN 11-04-2025
- BLTE 11-10-2025
- Dividend Yield
- DRVN N/A
- BLTE N/A
- EPS Growth
- DRVN N/A
- BLTE N/A
- EPS
- DRVN N/A
- BLTE N/A
- Revenue
- DRVN $2,439,296,000.00
- BLTE N/A
- Revenue This Year
- DRVN N/A
- BLTE N/A
- Revenue Next Year
- DRVN $7.91
- BLTE N/A
- P/E Ratio
- DRVN N/A
- BLTE N/A
- Revenue Growth
- DRVN 18.60
- BLTE N/A
- 52 Week Low
- DRVN $13.62
- BLTE $49.00
- 52 Week High
- DRVN $19.74
- BLTE $124.73
- Technical
- Relative Strength Index (RSI)
- DRVN 37.00
- BLTE 66.19
- Support Level
- DRVN $13.62
- BLTE $102.00
- Resistance Level
- DRVN $15.93
- BLTE $124.73
- Average True Range (ATR)
- DRVN 0.51
- BLTE 6.53
- MACD
- DRVN -0.06
- BLTE 0.23
- Stochastic Oscillator
- DRVN 17.71
- BLTE 59.73
About DRVN Driven Brands Holdings Inc.
Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments include: Maintenance, Car Wash, Paint, Collision & Glass, and Platform Services. It derives maximum revenue from Maintenance Segment. Geographically, the company operates into United States, Canada and Rest of the World.
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.